We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioLineRx's EDP-14 to Enter the Company's Main Therapeutic Pipeline as BL-9010

News   Jul 30, 2013

 
BioLineRx's EDP-14 to Enter the Company's Main Therapeutic Pipeline as BL-9010
 
 
 

RELATED ARTICLES

Our Microbiome Is What We Eat

News

A high-quality diet is linked to more potentially beneficial bacteria in the gut; while a low-quality diet is associated with an increase in potentially harmful bacteria. Modifying the microbiome through diet may therefore be part of a strategy to reduce the risk of chronic diseases.

READ MORE

Controlling HIV Infection by Reprogramming Immune Cells

News

Scientists have described the characteristics of CD8 immune cells in "HIV controller" patients and used the information on the unique antiviral power of these immune cells to reprogramme cells from individuals who can't fight the infection.

READ MORE

Larger, Earlier Drug Trials Needed to Fight Alzheimer's

News

There are currently no drugs that stop or inhibit Alzheimer's disease. Despite drug trials showing plaque reduction in the brain, the patients' cognitive function did not improve. Would the results be different if it were possible to design studies that intervene much earlier on in the disease, before cognition is affected?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE